In glioblastoma cell lines, CRISPR-CAS9-mediated deletion of homeotic2-like protein (ASH2L), a transcriptional regulator, leads to less TRA2β expression, along with glioblastoma cell apoptosis, and cell cycle arrest, through reducing cell cycle genes, such as TRA2β [44]. This evidence concerns the gene ASH2L and glioblastoma.